ETM
HITK

Euclidean Technologies Management’s HI-TECH PHARMACAL INC HITK Stock Holding History

Euclidean Technologies Management’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-90,879
Closed -$3.94M – 44
2014
Q1 		$3.94M Sell
90,879
-200
-0.2% -$8.67K 3.44% 10
2013
Q4 		$3.95M Buy
+91,079
New +$3.94M 3.61% 3

Euclidean Technologies Management's HITK Position: Q2 2014 in Review

Euclidean Technologies Management sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 90,879 shares — an estimated $3.94M sold.

Euclidean Technologies Management first reported a position in HITK in Q4 2013 and held it in 2 quarters. The position peaked at $3.95M in Q4 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Euclidean Technologies Management reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Euclidean Technologies Management sold 90,879 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $3.94M.
  • Euclidean Technologies Management first reported a position in HI-TECH PHARMACAL INC in Q4 2013 and held it in 2 quarters.
  • Euclidean Technologies Management's HI-TECH PHARMACAL INC position peaked at $3.95M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Euclidean Technologies Management's 13F filing for Q2 2014, filed 13 Aug 2014.